01 1BIOFER SPA
01 1Samoh Pharmaceutical Co., Ltd.
01 1Polymaltose ferric hydroxide salt
01 1Italy
Polymaltose ferric hydroxide salt
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2022-01-10
Registration Number : 20220110-211-J-1113
Manufacturer Name : BIOFER SPA
Manufacturer Address : Via Canina, 2 - 41036 MEDOLLA (MO), Italy
A Iron III Hydroxide Polymaltose Complex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iron III Hydroxide Polymaltose Complex, including repackagers and relabelers. The FDA regulates Iron III Hydroxide Polymaltose Complex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iron III Hydroxide Polymaltose Complex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Iron III Hydroxide Polymaltose Complex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Iron III Hydroxide Polymaltose Complex supplier is an individual or a company that provides Iron III Hydroxide Polymaltose Complex active pharmaceutical ingredient (API) or Iron III Hydroxide Polymaltose Complex finished formulations upon request. The Iron III Hydroxide Polymaltose Complex suppliers may include Iron III Hydroxide Polymaltose Complex API manufacturers, exporters, distributors and traders.
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Iron III Hydroxide Polymaltose Complex Drug Master File in Korea (Iron III Hydroxide Polymaltose Complex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Iron III Hydroxide Polymaltose Complex. The MFDS reviews the Iron III Hydroxide Polymaltose Complex KDMF as part of the drug registration process and uses the information provided in the Iron III Hydroxide Polymaltose Complex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Iron III Hydroxide Polymaltose Complex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Iron III Hydroxide Polymaltose Complex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with KDMF on PharmaCompass.
We have 1 companies offering Iron III Hydroxide Polymaltose Complex
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?